Cell-free DNA: predictive tissue injury maps in COVID-19

Cell-free DNA: predictive tissue injury maps in COVID-19


This webinar is a recorded presentation of a live broadcast and includes a pre-test, the presentation, handout, and a post-test. Continuing education credit is available for the webinar.


This interactive live webinar is part 6 of the 8 part Utility of Cell-Free DNA in the Clinic Series.

Description:

In this webinar, we will review the application of cell-free DNA to define the sources of tissue injury that are associated with the different COVID-19 manifestations. We will also examine the tissue injury patterns to identify COVID-19 patients who will develop severe disease and complications

Learning Objectives:

  • Describe the components of Cell-free DNA (cfDNA), and its dynamics in health and disease.
  • Describe the utility of cell-free DNA to identify early stages of disease before clinical manifestations develop
  • Identify challenges, and list possible solutions, unique to cfDNA assay validation.
  • Discuss the unique advantages and disadvantages of alternate sources of cfDNA.





    Speaker:
    Sean Agbor-Enoh, MD, PhD
    Moderator:
    Marjorie Parker David, MD, MS
    Duration: 1 Hour
    Level of Instruction: Basic

    Supported by an educational grant from AstraZeneca and by educational funding provided by Amgen.  

    How to Register:
    1. Click the "Enroll" Button
    2. Log in using your AMP credentials. If you do not have an AMP account, Create a FREE account by clicking here.
    3. Complete the "Demographic questionnaire for the "Utility of Cell-Free DNA in the Clinic Series" before the webinar date. You will only need to do this once for the entire series.

    Continuing Education Credit Information

    CME credit: 1.0
    CMLE credit: 1.0 
    Last day to claim credit: December 31, 2023 


    Physicians (ACCME)           


    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Association for Molecular Pathology.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Credit Designation Statement – Amedco LLC designates this live to enduring activity for a maximum of 8.00 AMA PRA Category 1 CreditsTM (1.00 CE for each webinar). Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    Medical Laboratory Education (CMLE)

    This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology as meeting the criteria for up to 8 CMLE credits. ASCP CMLE credits are acceptable to meet the continuing education requirement for the ASCP Board of Registry Certification Maintenance Program.


    Note: Join the AMP Family for discounted access to the most current educational resources!

    All sales are final. No refunds will be issued.

    No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation